Editorial: Resecting Assumptions—Do Proctocolectomy Guidelines Hold Up? Author's Reply
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Erik Lundqvist, Pär Myrelid, Caroline Nordenvall |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease
by: Erik Lundqvist, et al.
Published: (2025)
by: Erik Lundqvist, et al.
Published: (2025)
Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021
by: Mehdi Osooli, et al.
Published: (2025)
by: Mehdi Osooli, et al.
Published: (2025)
Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
by: José Luis Rueda García, et al.
Published: (2026)
by: José Luis Rueda García, et al.
Published: (2026)
Editorial: UDCA Dosing in PBC—Between Guideline Adherence and Clinical Reality: Authors' Reply
by: Ellen Werner, et al.
Published: (2026)
by: Ellen Werner, et al.
Published: (2026)
Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection. Authors' Reply
by: Elisa Pinto, et al.
Published: (2026)
by: Elisa Pinto, et al.
Published: (2026)
Editorial: Do we Need to Adapt GERD Metrics Based on the Population Being Evaluated? Authors' Reply
by: Walter W. Chan, et al.
Published: (2026)
by: Walter W. Chan, et al.
Published: (2026)
Editorial: Getting to the Heart of the Matter in IBD—Authors' Reply
by: Ramin Ebrahimi, et al.
Published: (2025)
by: Ramin Ebrahimi, et al.
Published: (2025)
Letter: Early Ileal Resection in Crohn's Disease Is Not Associated With Severe Long‐Term Outcomes: The ERIC Study: Authors' Reply
by: Nathan Grellier, et al.
Published: (2025)
by: Nathan Grellier, et al.
Published: (2025)
Treatment‐Free Outcomes Following Surgery for IBD : A Nationwide Cohort Study
by: Adam S. Faye, et al.
Published: (2025)
by: Adam S. Faye, et al.
Published: (2025)
Editorial: Association of Antibiotic Exposure With Microscopic Colitis—Authors' Reply
by: Máté Szilcz, et al.
Published: (2025)
by: Máté Szilcz, et al.
Published: (2025)
Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply
by: Jianhui Zhao, et al.
Published: (2024)
by: Jianhui Zhao, et al.
Published: (2024)
Editorial: To Stop or Not to Stop, Is It Still a Question? Authors' Reply
by: Jeongkuk Seo, et al.
Published: (2024)
by: Jeongkuk Seo, et al.
Published: (2024)
Editorial: Predicting Hepatocellular Cancer in Clinical Practice. Authors' Reply
by: Shuaibing Ying, et al.
Published: (2026)
by: Shuaibing Ying, et al.
Published: (2026)
Editorial: Cephalosporin‐Induced Liver Injury—Interesting but Tricky. Authors' Reply
by: Raj Vuppalanchi, et al.
Published: (2025)
by: Raj Vuppalanchi, et al.
Published: (2025)
Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
by: Fai Fai Ho, et al.
Published: (2025)
by: Fai Fai Ho, et al.
Published: (2025)
Editorial: The Hidden Burden—Stigmatisation in Inflammatory Bowel Disease: Authors' Reply
by: Suprabhat Giri, et al.
Published: (2025)
by: Suprabhat Giri, et al.
Published: (2025)
Editorial: Intestinal Ultrasound for the Assessment of Constipation—Out of the Shadows? Authors' Reply
by: Ryan M. Mathias, et al.
Published: (2025)
by: Ryan M. Mathias, et al.
Published: (2025)
Editorial: Revolutionising Steatotic Liver Disease Diagnosis With Phosphatidylethanol—Authors' Reply
by: Federica Tavaglione, et al.
Published: (2025)
by: Federica Tavaglione, et al.
Published: (2025)
Editorial: Targeting Urgency in IBD —A Historical Divide. Authors' Reply
by: Parul Tandon, et al.
Published: (2025)
by: Parul Tandon, et al.
Published: (2025)
Editorial: Are Antidepressant Medications Safe in Inflammatory Bowel Disease? Authors' Reply
by: Bharati Kochar, et al.
Published: (2025)
by: Bharati Kochar, et al.
Published: (2025)
Editorial: Seton Use in Perianal Fistulising Crohn's Disease. Authors' Reply
by: Jeffrey D McCurdy, et al.
Published: (2025)
by: Jeffrey D McCurdy, et al.
Published: (2025)
Editorial: The Role of Liver Biopsy in ANA Positive Subjects. Authors' Reply
by: David Mehdi Asgher Niazi, et al.
Published: (2026)
by: David Mehdi Asgher Niazi, et al.
Published: (2026)
Editorial: The Devil Is in the Detail—Interpreting the Findings of Network Meta‐Analyses. Authors' Reply
by: Mohammad Shehab, et al.
Published: (2025)
by: Mohammad Shehab, et al.
Published: (2025)
Editorial: Redefining Decompensation in Cirrhosis—More Than an Academic Playground? Authors' Reply
by: Lucie Simonis, et al.
Published: (2025)
by: Lucie Simonis, et al.
Published: (2025)
Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population. Authors' Reply
by: Daniel Q. Huang, et al.
Published: (2026)
by: Daniel Q. Huang, et al.
Published: (2026)
Editorial: Diabetes Management in Cirrhosis—The Window of Opportunity Before Decompensation. Authors' Reply
by: Mary Yue Wang, et al.
Published: (2026)
by: Mary Yue Wang, et al.
Published: (2026)
Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply
by: Jiong Yu, et al.
Published: (2024)
by: Jiong Yu, et al.
Published: (2024)
Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction—Do Existing Scores Clear the Bar? Authors' Reply
by: Lesley A. Patmore, et al.
Published: (2025)
by: Lesley A. Patmore, et al.
Published: (2025)
Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker‐Based Strategy—Authors' Reply
by: Tanat Saeoui, et al.
Published: (2025)
by: Tanat Saeoui, et al.
Published: (2025)
Editorial: Combination Therapies for MASH : A Step Forward or More Complexity? Authors' Reply
by: Eric Lawitz, et al.
Published: (2025)
by: Eric Lawitz, et al.
Published: (2025)
Editorial: Inflammatory Bowel Disease and Dietary Emulsifiers—A Conundrum That Continues. Authors' Reply
by: Jessica A. Fitzpatrick, et al.
Published: (2025)
by: Jessica A. Fitzpatrick, et al.
Published: (2025)
Editorial: Implementing Risk Assessment Tools for MetALD in Clinical Practice—Authors' Reply
by: Nikolaj Torp, et al.
Published: (2025)
by: Nikolaj Torp, et al.
Published: (2025)
Editorial: Managing the Moving Target—Dose Adjustments in Inflammatory Bowel Disease. Authors' Reply
by: Cristina Rubín de Célix, et al.
Published: (2025)
by: Cristina Rubín de Célix, et al.
Published: (2025)
Editorial: When and What to Ask—Capturing the Symptoms Experienced by Patients With PSC. Authors' Reply
by: Natassia Tan, et al.
Published: (2025)
by: Natassia Tan, et al.
Published: (2025)
Editorial: H. pylori Treatment—Old Ingredients in New Effective Regimens. Authors' Reply
by: Olga P. Nyssen, et al.
Published: (2025)
by: Olga P. Nyssen, et al.
Published: (2025)
Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis—The Fat of the Matter: Authors' Reply
by: Aakash Desai, et al.
Published: (2025)
by: Aakash Desai, et al.
Published: (2025)
Editorial: TIPS in the Era of Aging and Metabolic Comorbidity—Rethinking Risks and Rewards. Authors Reply
by: Michelle Spaan, et al.
Published: (2026)
by: Michelle Spaan, et al.
Published: (2026)
Editorial: The Milan Score as Supportive Evidence of Gastro‐Oesophageal Reflux Disease. Authors' Reply
by: Stefano Siboni, et al.
Published: (2026)
by: Stefano Siboni, et al.
Published: (2026)
Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply
by: Jian Wang, et al.
Published: (2025)
by: Jian Wang, et al.
Published: (2025)
Editorial: Toward Safer Pain Management in IBD—Lessons From Prescription Patterns. Authors' Reply
by: Samantha Baillie, et al.
Published: (2025)
by: Samantha Baillie, et al.
Published: (2025)
Similar Items
-
Outcome After Surgery for Colon Cancer in a National Cohort of Patients With and Without Inflammatory Bowel Disease
by: Erik Lundqvist, et al.
Published: (2025) -
Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021
by: Mehdi Osooli, et al.
Published: (2025) -
Editorial: Beyond Resection—Rethinking Postoperative Management in Colonic Crohn's Disease. Authors' Reply
by: José Luis Rueda García, et al.
Published: (2026) -
Editorial: UDCA Dosing in PBC—Between Guideline Adherence and Clinical Reality: Authors' Reply
by: Ellen Werner, et al.
Published: (2026) -
Letter: Tumour Burden Score for Predicting Extrahepatic Metastasis in Hepatocellular Carcinoma After Curative Resection. Authors' Reply
by: Elisa Pinto, et al.
Published: (2026)